In the press

Press releases & News

Lavie Bio Announces Advancement in its Product Development Pipeline for Wheat Bio-Stimulants

Leading wheat bio-stimulant candidate for spring wheat, exhibiting consistent performance, advancing to ‘development stage 2’, in line with Lavie Bio’s commercialization plans for 2022 Rehovot, Israel – November 18, 2019 – Lavie Bio (Lavie), a subsidiary of Evogene (NASDAQ: EVGN, TASE: EVGN), aiming to improve food quality, sustainability and agriculture productivity through the introduction of

Read more

James Presnail has joined Lavie Bio as Chief Operating Officer.

In this position Jim will lead operational aspects and downstream development and commercialization efforts of Lavie Bio’s product pipeline as well as heading the Lavie Bio US site in St. Louis, Missouri.   Jim previously served as VP R&D and Director of Molecular Biology and Analytics at Calyxt. Prior to Calyxt, Jim was the Director

Read more

Lavie Bio, Evogene’s Ag-Biologicals Subsidiary, Announces the Nomination of Industry Experts to its Board of Directors

The nomination of industry experts is expected to support the company’s management in execution of its product development and commercialization roadmap  Rehovot, Israel – September 11, 2019 – Lavie Bio, a subsidiary of Evogene (NASDAQ, TASE: EVGN), focusing on improving food quality, agricultural sustainability and productivity through the development of novel microbiome based agriculture biological

Read more